D DEXCOM INC
| Market Cap | $24.27B |
| P/E Ratio | 29.77 |
| Forward P/E | 20.80 |
| Dividend Yield | — |
| Beta | 1.56 |
| 52W Range | $54.84 - $89.53 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 0.00% | $3.00K | 58 | Buy |
Insider Trading
| Insider Name of the company insider who made the trade 7 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Brown Michael JonEVP, Chief Legal Officer | Sale | 1,700 | $64.85 | $110.25K | 16 Mar 2026 | 16 Mar 2026 |
| Heller Bridgette P | Sale | 1,012 | $68.01 | $68.83K | 12 Feb 2026 | 17 Feb 2026 |
| Collins Richard Alexander | Sale | 2,906 | $59.05 | $171.60K | 14 Nov 2025 | 17 Nov 2025 |
| Heller Bridgette P | Sale | 1,012 | $58.07 | $58.77K | 12 Nov 2025 | 12 Nov 2025 |
| Leach Jacob StevenPresident & COO | Buy | 2,500 | $55.43 | $138.56K | 10 Nov 2025 | 10 Nov 2025 |
| Collins Richard Alexander | Sale | 3,948 | $55.17 | $217.81K | 10 Nov 2025 | 10 Nov 2025 |
| Leach Jacob StevenPresident & COO | Buy | 15,700 | $54.98 | $863.14K | 10 Nov 2025 | 10 Nov 2025 |
Frequently Asked Questions
What is DXCM stock price today?
DEXCOM INC (DXCM) is currently trading at $62.22. The stock has a 52-week range of $54.84 to $89.53 and a market capitalization of $24.27B.
Is DXCM a good stock to buy in 2026?
DEXCOM INC has a P/E ratio of 29.8 (forward P/E: 20.8), a dividend yield of none, and 1-year performance of +0.7%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling DXCM stock?
There have been 7 insider transactions for DXCM in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has DXCM stock performed over the past year?
DEXCOM INC (DXCM) has returned +0.7% over the past 12 months. The stock traded between $54.84 and $89.53 during this period, and is currently at $62.22.
Which hedge funds own DXCM (DEXCOM INC)?
1 tracked hedge funds currently hold DXCM in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is DXCM's market cap and valuation?
DEXCOM INC (DXCM) has a market capitalization of $24.27B. The trailing P/E ratio is 29.8 and forward P/E is 20.8. The stock is classified in the Healthcare sector.
What is DXCM's revenue and profitability?
DEXCOM INC reported revenue of $4.66B with net income of $836.30M and a profit margin of 0.18%. The stock has a beta of 1.56.
What sector is DXCM in and who are its biggest institutional holders?
DEXCOM INC (DXCM) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.